
TG Cardis 145mg Tablet
Marketer
Ckris Laboratories Pvt Ltd
Salt Composition
Fenofibrate (145mg)
Overview TG Cardis 145mg Tablet
CardioLipid 145mg tablets effectively manage high cholesterol. This medication reduces harmful triglycerides and LDL ("bad") cholesterol, concurrently boosting beneficial HDL ("good") cholesterol. Lower cholesterol levels mitigate the risk of stroke and heart attack. Always adhere to your physician's prescribed dosage and duration for CardioLipid 145mg tablets; timing is flexible, but consistency is key. High cholesterol often presents without symptoms, however discontinuing treatment may exacerbate the condition, elevating cholesterol and increasing cardiovascular risks. Regular cholesterol monitoring is essential. This medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, smoking cessation, responsible alcohol consumption, and weight management. Maintain a normal diet, minimizing high-fat foods. Nausea, abdominal discomfort, diarrhea, and vomiting are potential side effects. Inform your doctor of all current medications before commencing treatment. Caution is advised for individuals with liver or kidney disease; pregnant or breastfeeding women should consult their physician before use.
Primary Ingredients of TG Cardis 145mg Tablet
No text was provided to rewrite.
Uses of TG Cardis 145mg Tablet
Elevated cholesterol and triglyceride levels
Major Benefits of TG Cardis 145mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 145mg TG Cardis tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with food.
Common Side effects of TG Cardis 145mg Tablet:
- Abdominal pain
- Diarrhea
- Nausea
- Headache
- Flatulence
- Vomiting
- Increased liver enzymes
- Increased creatine phosphokinase (CPK) level in blood
- Back pain
- Inflammation of the nose
How to use TG Cardis 145mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the 145mg TG Cardis tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How TG Cardis 145mg Tablet works:
Cardis 145mg tablets reduce lipid levels. This medication lowers triglycerides and low-density lipoprotein (LDL) cholesterol, concurrently increasing high-density lipoprotein (HDL) cholesterol.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking TG Cardis 145mg Tablets.
PregnancyCONSULT YOUR DOCTOR
The use of TG Cardis 145mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Use of the medication TG Cardis 145mg Tablet while breastfeeding is likely inadvisable. Preliminary data from human studies indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by TG Cardis 145mg Tablets.
KidneyCAUTION
Patients with kidney impairment should use TG Cardis 145mg Tablets cautiously, potentially requiring dosage modification under medical supervision. The use of TG Cardis 145mg Tablets is contraindicated in individuals with severely compromised kidney function.
LiverUNSAFE
Individuals with liver impairment should likely refrain from using TG Cardis 145mg Tablets due to potential safety concerns. Medical advice is recommended. The use of TG Cardis 145mg Tablets is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take TG Cardis 145mg Tablet :
Should you forget a dose of TG Cardis 145mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About TG Cardis 145mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Fibric acid-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Fibrate drugs (PPARα agonists) |
